Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Pure Positive Allosteric Modulators (PAMs) of mGlu5 with Competitive MPEP-Site Interaction

In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010.
[updated ].
Free Books & Documents
Review

Pure Positive Allosteric Modulators (PAMs) of mGlu5 with Competitive MPEP-Site Interaction

Ya Zhou et al.
Free Books & Documents

Excerpt

A series of acetylenic biaryl mGlu5 positive allosteric modulators (PAMs) have been optimized as pure potentiators in low receptor expressing mGlu5 cell lines. ML254 was identified and shown to competitively interact with the MPEP allosteric binding site. Preliminary data from electrophysiological recordings in native tissues measuring long-term depression (LTD) of transmission at the hippocampal Schaffer collateral synapse (SC-CA1) further establish a pure potentiator mode of action for ML254. ML254 is highly selective for mGlu5 versus other mGlu receptors, has a clean ancillary Ricerca profile, and suitable dystrophia myotonica protein kinase (DMPK) properties for systemic dosing in rodents. Preliminary experiments at a single dose in an in vivo model of psychosis using ML254 demonstrates a robust reversal of amphetamine induced hyperlocomotion. ML254 will serve as a significant pure-PAM tool compound for the field with potential for studies within in vivo paradigms. Structure activity relationship (SAR) and characterization of ML254 are described.

PubMed Disclaimer

Similar articles

References

    1. Solubility (PBS at pH = 7.4), Stability and Reactivity experiments were conducted at Analiza. For additional information see: http://analiza.com

    1. For information on the Ricerca Lead Profiling Screen see: https://www.eurofinspanlabs.com/Catalog

    1. Stauffer SR. Progress towards positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5) ACS Chemical Neuroscience. 2011;2:450–470. - PMC - PubMed
    1. Lindsley CW, Stauffer SR. Metabotropic glutamate receptor 5 (mGlu5) positive allosteric modulators (PAMs) for the treatment of schizophrenia: a review of the patent literature 2004–2012. Expert Opin Ther Patents. 2012 in press.
    1. Spear N, Gadient RA, Wilkins DE, Do M, Smith JS, Zeller KL, Schroeder P, Zhang M, Arora J, Chhajlani V. Preclinical profile of a novel metabotropic glutamate receptor 5 positive allosteric modulator. Eur J Pharmacol. 2011;659:146–54. - PubMed

LinkOut - more resources